Cowen analyst Yaron Werber defending Epizyme (NASDAQ: EPZM) on label concerns.Werber commented, "We are getting questions on the EPZM label ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE